Background We sought to identify determinants of health-related quality of life after primary
treatment of prostate cancer and to measure the effects of such determinants on satisfaction …

Multiple, complex molecular events characterize cancer development and progression 1 , 2
. Deciphering the molecular networks that distinguish organ-confined disease from …

Background The effectiveness of surgery versus observation for men with localized prostate
cancer detected by means of prostate-specific antigen (PSA) testing is not known. Methods …

Objectives. Health-related quality of life (HRQOL) is an increasingly important endpoint in
prostate cancer care. However, pivotal issues that are not fully assessed in existing HRQOL …

Purpose : To revise the 2003 version of the American Urological Association's (AUA) Guideline
on the management of benign prostatic hyperplasia (BPH). Materials and Methods : From …

Noncoding RNAs (ncRNAs) are emerging as key molecules in human cancer, with the
potential to serve as novel markers of disease and to reveal uncharacterized aspects of tumor …

Despite efforts to profile prostate cancer, the genetic alterations and biological processes
that correlate with the observed histological progression are unclear. Using laser-capture …

Molecular profiling of cancer at the transcript level has become routine. Large-scale analysis
of proteomic alterations during cancer progression has been a more daunting task. Here, …

Background Medical therapies to ease urinary-stone passage have been reported, but are
not generally used. If effective, such therapies would increase the options for treatment of …

Purpose : Benign prostatic hyperplasia (BPH), the most common benign neoplasm in
American men, is a chronic condition that is associated with progressive lower urinary tract …